中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Iridal-type triterpenoids with anti-HBV activity from Iris confusa

文献类型:期刊论文

作者Chen, Xinglong1,2; Zhang, Xiuqiong1,2; Ma, Yunbao1,2; Deng, Zhentao1,2; Geng, Changan1,2; Chen, Jijun1,2
刊名FITOTERAPIA
出版日期2018-09-01
卷号129页码:126-132
关键词Iris confusa Iridal-type triterpenoids Anti-HBV activity
ISSN号0367-326X
DOI10.1016/j.fitote.2018.06.005
英文摘要Five new iridal-type triterpenoids, named as spirioiridoconfal A-C (1-3), isobelamcandal (4) and 17-hydroxyl-27-ene-iridal (5), along with one known compound (6) were isolated from the whole plant of Iris confusa. Their structures were determined by extensive spectroscopic analyses. Compounds 3 and 6 showed moderate activity against HBV DNA replication in vitro with the IC50 value at 84.6 +/- 24.9 (SI = 2.1) and 58.6 +/- 6.1 (SI = 12.7) mu M relatively.
资助项目Hundred Talents Program of the Chinese Academy of Sciences ; Program of Yunling Scholar of the Chinese Academy of Sciences
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000443663800018
出版者ELSEVIER SCIENCE BV
资助机构Hundred Talents Program of the Chinese Academy of Sciences ; Program of Yunling Scholar of the Chinese Academy of Sciences
源URL[http://ir.kib.ac.cn/handle/151853/62300]  
专题昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室
通讯作者Chen, Jijun
作者单位1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, 132 Lanhei Rd, Kunming 650201, Yunnan, Peoples R China
2.Yunnan Key Lab Nat Med Chem, Kunming 650201, Yunnan, Peoples R China
推荐引用方式
GB/T 7714
Chen, Xinglong,Zhang, Xiuqiong,Ma, Yunbao,et al. Iridal-type triterpenoids with anti-HBV activity from Iris confusa[J]. FITOTERAPIA,2018,129:126-132.
APA Chen, Xinglong,Zhang, Xiuqiong,Ma, Yunbao,Deng, Zhentao,Geng, Changan,&Chen, Jijun.(2018).Iridal-type triterpenoids with anti-HBV activity from Iris confusa.FITOTERAPIA,129,126-132.
MLA Chen, Xinglong,et al."Iridal-type triterpenoids with anti-HBV activity from Iris confusa".FITOTERAPIA 129(2018):126-132.

入库方式: OAI收割

来源:昆明植物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。